Pfizer, Moderna COVID-19 vaccines could reach all Americans by June—if politics don't get in the way: Slaoui CDC working with Warp Speed, local jurisdictions on nationwide COVID-19 vaccine plan: official FDA study finds fear and distrust among front-line workers and minority groups around COVID-19 vaccines United Airlines tests COVID-19 'health pass' app to bring back global travel Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine trial participants Cue Health nets $481M DOD contract to deliver hand-held coronavirus tests HHS secretary Azar discussed firing FDA chief Hahn after showdown over COVID-19 vaccine guidance: Politico AMGA presses HHS to walk back new reporting requirements for COVID-19 relief funding Biopharma roundup: Moderna completes trial enrollment; Experts talk distribution, vaccine confidence at FDA hearing Healthcare roundup: HIV prevention medication fills decline amid pandemic Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work Quest Diagnostics ups guidance, notches major sales growth and gives back CARES Act cash Pharma and healthcare digital advertising jumps during pandemic: report Featured Story | By Arlene Weintraub Operation Warp Speed co-leader Moncef Slaoui predicts that mRNA COVID-19 vaccines from Moderna and Pfizer will succeed and that every American could be vaccinated by June. But recent polls suggest only half of people are willing to get the shot—a problem Slaoui blames on politics. read more |
| |
|---|
|
| | Webinar: The Power of Virtual Health Assessments during COVID Tuesday, October 27 | 11am ET / 8am PT COVID-19 has forced us to rethink how we effectively support members, and manage quality improvement and risk adjustment initiatives. This webinar provides a look at how Virtual Health Assessments improve healthcare outcomes for members, providers, and payers. Explore how Advantmed’s telehealth solution supports quality improvement and risk adjustment. Register Today. |
Top Stories By Eric Sagonowsky In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic. Concerns remain, though, and, amid that backdrop, top government expert took a chance Thursday to discuss safety and efficacy requirements, distribution plans and vaccine confidence—plus more. read more By Beth Snyder Bulik FDA researchers uncovered more worries about a coronavirus vaccine. The nonprofit Reagan-Udall Foundation for the FDA is currently in listening mode on an FDA project focused on two key audiences: front-line workers, including healthcare and retail employees, and traditionally underrepresented groups, including Black, LatinX and Native Americans. Some of their comments were troubling. read more By Heather Landi United Airlines tested this week a digital health pass on a flight from London to Newark, New Jersey, as part of a program to enable safer global travel and accelerate border reopenings. Here's how the digital health app works and how soon it could be offered on other flights. read more By Eric Sagonowsky Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial of mRNA-1273. The trial, testing the vaccine candidate against placebo in 30,000 participants, includes thousands of people from communities of color and thousands at higher risk of severe coronavirus. read more By Conor Hale After raising $100 million this year, Cue Health has received another $481 million from the U.S. Department of Defense to dramatically ramp up production of its hand-held diagnostic test for COVID-19, with plans to deliver 6 million tests to the federal government over the next six months. read more By Eric Sagonowsky President Donald Trump touted a COVID-19 vaccine ready for Election Day, and behind the scenes, his officials tried to make it happen. But despite intense pressure, the FDA publicly rolled out stricter safety guidelines that thwarted those hopes—and now Commissioner Stephen Hahn is reportedly at odds with his boss, HHS chief Alex Azar. read more By Robert King The American Medical Group Association is imploring Health and Human Services to nix changes to how providers report data to get COVID-19 relief funding, arguing the new system will hinder medical groups' ability to get the vital money. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner The FDA held its much-anticipated public hearing about COVID-19 vaccine development Thursday, and experts covered subjects ranging from distribution plans to vaccine confidence. Meanwhile, industry officials wrote an open letter supporting NIAID director Anthony Fauci, and Moderna completed enrollment for its big phase 3 trial. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Angus Liu As major drugmakers race to develop effective COVID-19 vaccines, a rogue's gallery of bad state actors have been pegged behind a series of data breaches into critical research. Now, an Indian generics maker has been hit with a potential cyberattack, and it's shutting down some of its plants to isolate the problem. read more By Ben Adams There are many companies losing out over the economic impact of the pandemic, but Quest Diagnostics is one that is booming as a result. read more By Sharon Klahr Coey Pharma and healthcare digital advertising is expected to increase to more than $9.5 billion this year, according to media researcher eMarketer. That's an increase of 14% over last year and puts the industry in the number two spot for growth, according to new report. read more |
